The Oxford Parkinson's Disease Centre and the Center for Neurology and Hertie Institute for Clinical Brain Research, Department for Neurodegeneration are unique multidisciplinary research centres. These centres bring together internationally-renowned scientists who work on the genetics of PD, the generation of cell and animal models, and the wiring of brain circuits which control movement, with clinical experts in the diagnosis and treatment of PD. In the course of CENTRE-PD, they will transfer knowledge to the Luxembourg Centre of Systems Biomedicine at the University of Luxembourg.
Click the logo of the institution to read about the complimentary expertise:
|Oxford Parkinson's Disease Centre||Prof. Dr. Michele Hu|
|Center for Neurology Tübingen||
Prof. Dr. Thomas Gasser
|Luxembourg Centre for Systems Biomedicine||Prof. Dr. Rejko Krüger|
The following partners will contribute to the successful implementation of the CENTRE-PD goals:
The LIH as a public research centre aiming at translational biomedical research and plays an important role in the recruitment of healthy controls in the PD cohort. CENTRE-PD will further encourage the bridging between LIH and LCSB/UL, thus creating stronger links within Luxembourg’s research to gain critical mass.
The Clinical platform is established by the CHL together with other clinical facilities in Luxembourg and will support the broad recruitment of patients with parkinsonism, clinical assessments as well as sample and data collection during the PD cohort.
The Biobanking platform is established by the IBBL and with the help of the LCSB will support sample collection, processing, analysis, storage and management.
The PD patient initiative offered by APL will also contribute to patient recruitment and support the public outreach activities planned within CENTRE-PD.